Takeda Pharma GmbH
- Pharmaceutical Sales 2009
-
worldwide: 11.7 billion Euro
in Germany: 278 million Euro
- Product Range
- Cardiovascular diseases, diabetes-type-2, urogenital diseases (endometriosis, prostate cancer), gastroenterologic diseases, oncology (osteosarcoma), COPD
- Key Research Areas
- diabetes, cardiovascular diseases, prostate cancer, bone and joint diseases, gastroenterology, Alzheimer, septicaemia, hematology
- R&D Expenditure 2009
-
worldwide: 2.36 billion Euro
- Employees in the Pharmaceuticals Division 2008
-
worldwide: 19,000
in Germany: 550
(All data based on corporate information, as of: 05/2010)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Suggest page
Print page
Bookmark page